Phase II studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic, or recurrent esophageal cancer

• 作者M. Albertsson; B. Johansson; S. Friesland; L. Kadar; H. Letocha; G. Frykholm; G. Wagenius
• 卷第24卷
• 期第4期
• 印刷ISSN1357-0560
• 电子ISSN1559-131X
• 文件大小132.74KB
• 发表时间2007-12
• DOI10.1007/s12032-007-0028-6
• 页码407-412